Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Shares Outstanding (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Shares Outstanding for 5 consecutive years, with $29.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.38% to $29.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.2 million through Dec 2025, up 1.38% year-over-year, with the annual reading at $29.2 million for FY2025, 1.38% up from the prior year.
  • Shares Outstanding hit $29.2 million in Q4 2025 for Krystal Biotech, up from $29.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $29.2 million in Q4 2025 to a low of $22.2 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $26.8 million across 5 years, with a median of $28.1 million in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 15.61% in 2022 and later rose 0.76% in 2025.
  • Year by year, Shares Outstanding stood at $25.2 million in 2021, then grew by 2.21% to $25.8 million in 2022, then grew by 9.6% to $28.2 million in 2023, then rose by 1.97% to $28.8 million in 2024, then grew by 1.38% to $29.2 million in 2025.
  • Business Quant data shows Shares Outstanding for KRYS at $29.2 million in Q4 2025, $29.0 million in Q3 2025, and $28.9 million in Q2 2025.